Clinical Trial Update: EUS-FNA for Retropharyngeal Lymph Node (RPLN) in Recurrent Nasopharyngeal Carcinoma (NPC) Patients [Phase 2, Phase 3]

View source ↗

Summary

This is a clinical trial update on using EUS-FNA for evaluating retropharyngeal lymph nodes in patients with recurrent nasopharyngeal carcinoma, covering Phase …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nasopharyngeal Carcinoma

Snippet

Sponsor: Sun Yat-sen University | Conditions: Nasopharyngeal Carcinoma | Phase 2, Phase 3 | Status: UNKNOWN